Moderna advances two vax candidates against Omicron variants

The company is one of a number of vaccine makers developing new shots to tackle BA.4 and BA.5
Reuters Health

Moderna is moving ahead with two Omicron vaccine candidates for the third quarter of the year.

One is designed against the BA.1 variant and another against BA.4 and BA.5.